Photo taken from Agenus/LinkedIn
Oct 24, 2023, 14:05
Agenus is proud to unveil the latest research from our investigational botensilimab programs – Agenus
Agenus shared a post on LinkedIn:
“Agenus is proud to unveil the latest research from our investigational botensilimab programs, showcasing significant advancements across our colorectal, pancreatic, lung, melanoma, and sarcoma studies. The data underscore botensilimab’s versatile potential in cold and treatment-resistant solid tumors, including the opportunity to expand into early-stage cancers supported by compelling outcomes in neoadjuvant colorectal cancer.
A live webcast will be hosted at 1:00 p.m. EDT to discuss these results. Learn more here.”
Source: Agenus/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14